S-1 · resale registration
Issued 2025
Proposed maximum
Shares registered
- Filed
- Effective
Sector: Pharmaceutical PreparationsIndustry: Drug Manufacturers - Specialty & GenericCountry: CAExchange: Nasdaq
DilutionScan read 52 of InMed Pharmaceuticals Inc.'s SEC filings and found 8 warrant series, 1 convertible, 1 ATM program, 1 equity line, 1 shelf registration, 2 S-1 registrations and 1 completed offering on file for INM. The latest dilution event on file is a registration statement on Mar 30, 2026. Analysis updated Nov 3, 2026.
Raise routes on file: active ATM + effective shelf + effective S-1 + active equity line · latest dilution event 218 days ago
The dominant contractual driver and its mechanism, then each further driver ranked.
Mar 30, 2026 · Registration
Every warrant, convertible, ATM and shelf, cited to the filing
A free account reads 3 tickers a day in full
$59/mo with 7 days free, or $49/mo billed yearly ($588/yr)
Shares outstanding, potential dilution and cash over time
Issued 2025
Proposed maximum
Shares registered
Issued 2024
Proposed maximum
Shares registered
Shares Underlying
Exercise Price
Issued 2025
Shares Underlying
Exercise Price
Issued 2025
Shares Underlying
Exercise Price
Issued 2023
Shares Underlying
Exercise Price
Issued 2023
Shares Underlying
Exercise Price
Shares Underlying
Exercise Price
Principal
Conversion Price
Issued 2022
Total capacity
Sold to date
Issued 2024
Commitment
Sold to date
Issued 2026
Total capacity
Remaining
Gross proceeds
Price per share
Exercise prices, conversion terms, shelf headroom and the filing sentence behind every number.
$59/mo with 7 days free, or $49/mo billed yearly ($588/yr)
DilutionScan ProEvery instrument in full · $59/mo
Covered companies in Drug Manufacturers - Specialty & Generic. All tickers A to Z